Industry growth Medical Devices

Neuilly-sur-Seine, January 18, 2012

Interest in the field of in vitro diagnostic medical shows strong growth

From 2012 to 2014, PwC expects a growth of investor interest in the medical diagnostic device in vitro (IVDMD) 1 industry. According to "Diagnosis 2011", the biennial PwC study on the IVDMD industry, this trend is due to the surge in the value of mergers and acquisitions in the sector, acceleration in the number of partnerships with industry drug tests on the two companions and the emergence of new prospects for early detection of observed past two years cancer.

During the first seven months of 2011, several transactions valued at over one billion dollars, contributed to more than triple the value of mergers and acquisitions in the industry IVDMD compared to 2010, surpassing the $ 15 billion .
According to "Diagnosis 2011", the renewed interest in the sector comes not only from historical market, but also new entrants such as financial investors, product research groups 3, the medical laboratories and companies specializing in medical devices. This arrival, coupled with the conclusion of transactions in higher values ​​than in the past, could redefine the competitive landscape of the industry, while several actors reinforce their market share. However, the sustainability of partnerships in the field of companion tests will depend on the measures to support innovation by governments, regulatory agencies and industry.

The "Diagnostics 2011" report looks at five factors that may influence the activity of mergers and acquisitions in the sector IVDMDs the 2012-2015 horizon:

  • pursuing acquisitions IVDMDs activities by new entrants;
  • the response of historical leaders to this new situation: in the absence of a major acquisition program, the historical leaders could see their market share decline in some key segments;
  • the private equity firm seeking opportunities: we can expect an increase in the number of acquisitions of high value-funded capital investment (Private Equity) - subject to the maintenance of capital markets;
  • large pharmaceutical companies buying up companies specializing in molecular or tissue diagnosis: Despite the small number of this type of movement in recent years, large pharmaceutical companies would be encouraged by the confirmation of the model of co-development of a drug and a diagnosis 4;
  • the entry of a big player in the field of early detection: Several companies are at the forefront of the development of a new wave of tests for the early detection of major cancers. It is difficult to predict whether the market will adopt the use of non-invasive screening for IVDMDs 5. If this is the case, it could push a big diagnostics company or pharmaceutical products to buy some promising young companies in the area of ​​early detection.
All news PwC RSS feed!

Revenue Growth Expectations in the Medical Devices Industry - 2011-2012: Survey Snapshot
Book (MarketResearch.com)
2003-10-02 06:38:37 by apathetichuman

Sorry for the delay

Had to sleep. Okay, not what you asked for, but, along the same lines. I will find the cream connection and post it later. These articles are all about the companies that pay lots of money for foreskin harvesting. Granted, some of their discoveries are for the betterment of medicine. However, they are all motivated by foreskin for money.
Don't believe it ? Read for yourself - directly from the companies involved - all about the massive foreskin-for-sale industry !
Periscope: Bionic Band-Aid
Newsweek Wednesday, January 13, 1999
Living Human Skin Equivalent Apligraf
Molecule of the Month February 1998
Bioengineered skin wins approval from the FDA
Wound Care newsletter July 1998
The Role of Tissue Engineering in Wound Care
AVF Newsletter American Venous...

You might also like:

New Tampa Foot And Ankle
New Tampa Foot And Ankle
Mike Sperduti
Mike Sperduti
Waterloo Accelerator Centre - Global City Award
Waterloo Accelerator Centre - Global City Award

Global Markets for Contract Pharmaceutical Manufacturing, Research and ..  — Sacramento Bee
..

Stanford
Stanford
NUTRICIDE PT 3 OF 4.wmv
NUTRICIDE PT 3 OF 4.wmv
Biotech Financial Solutions Launch Video
Biotech Financial Solutions Launch Video
SoCalBio Takes on Obesity: Part 8
SoCalBio Takes on Obesity: Part 8

Related posts:

  • Avatar jackzhlin How big is the medical device industry in terms of dollars?
    Nov 07, 2007 by jackzhlin | Posted in Other - Business & Finance

    As of 2007 - how big is this industry?

    • Datamonitor Industry Market Research, March 15, 2007 pNA Global - Health Care Equipment.(Industry overview) "*Surgical and medical equipment sales proved the most lucrative for the global health care market in 2006, generating total revenues of $98.1 billion, equivalent to 78.7% of the market s overall value. *The US region accounts for 46.3% of the global market s value in 2006. This compared to Europe, which accounts for 35% and Asia-Pacific with 16.7% of the market s value. " And here s similar data for the U.S.: Datamonitor Industry Market Research, June 16, 2007 …

  • Avatar asdfasdfasdfasdf What are some industries in the stock market that are and will be strong?
    Nov 23, 2007 by asdfasdfasdfasdf | Posted in Investing

    For example: Metals and mining, steel, shipping have been strong and will be from the growth of the world (and seem unstoppable!), what others are similar?

    • Metals and mining are good now, but be careful in the future with that one. It is not just global growth that is fueling metals, but also the falling dollar, and to a lesser extent inflation. There is a rush to commodities going on now, that is essentially a flight away from cash. If, in the future, the Fed increases interest rates and the dollar starts rising, watch out! Defensive non-cyclical staples stocks are pretty good now; like MO, PEP, & KO. Some hot stocks that are working are in medical devices like ISRG, or elec gadgets like AAPL & RIMM, or internet/software in general …